Abstract
Calcium entering via voltage-gated calcium channels is a second messenger key for cellular functions including gene expression, neuronal excitability, neurogenesis, neuronal differentiation, and neurotransmitter release. Alterations in these calcium-dependent processes have been observed in psychiatric disorders. Furthermore, genetic studies have identified associations of risk genetic variants of voltage-gated calcium channel genes (CACNA1A-I) with psychiatric disorders. Thus, these channels are becoming promising targets to treat these pathologies. In this chapter, we will discuss evidence linking calcium to psychiatric disorders, and then we will review key genetic studies that have found strong associations among voltage-gated calcium channel genes and psychiatric disorders. Next, we will examine the role of voltage-gated calcium channels in neurobiological mechanisms linked to psychiatric disorders. We will analyze evidence from animal models that link voltage-gated to behavioral endophenotypes observed in psychiatric disorders. Finally, we will discuss the current view and challenges to target these channels to treat psychiatric disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- ADHD:
-
attention deficit and hyperactivity disorder
- ASD:
-
autism spectrum disorder
- BD:
-
bipolar disorder
- BDNF:
-
brain-derived neurotrophic factor
- CaMKII:
-
Ca2/calmodulin-dependent protein kinase II
- CCK:
-
cholecystokinin
- CPu:
-
caudate putamen
- CREB:
-
cAMP response-element binding protein
- EA2:
-
episodic ataxia type 2
- eIF2α:
-
eukaryotic initiation factor 2α
- FHM1:
-
familial hemiplegic ataxia type 1
- FST:
-
forced-swim test
- GWAS:
-
genome-wide association study
- MDD:
-
major depressive disorder
- mTOR:
-
mammalian target of rapamycin
- NAc:
-
nucleus accumbens
- PV:
-
parvalbumin
- RDoC:
-
research domain criteria
- SCZ:
-
schizophrenia
- SNc:
-
substantia nigra pars compacta
- SNP:
-
single nucleotide polymorphism
- TS:
-
timothy syndrome
- TST:
-
tail suspension test
- VGCC :
-
voltage-gated calcium channel
- VTA:
-
ventral tegmental area
References
Albert, P. R., & Vahid-Ansari, F. (2019). The 5-HT1A receptor: Signaling to behavior. Biochimie, 161, 34–45.
Ament, S. A., Szelinger, S., Glusman, G., Ashworth, J., Hou, L., Akula, N., et al. (2015). Rare variants in neuronal excitability genes influence risk for bipolar disorder. Proceedings of the National Academy of Sciences of the United States of America, 112, 3576–3581.
Andrade, A., Hope, J., Allen, A., Yorgan, V., Lipscombe, D., & Pan, J. Q. (2016). A rare schizophrenia risk variant of CACNA1I disrupts CaV3.3 channel activity. Scientific Reports, 6, 34233.
Andrade, A., Brennecke, A., Mallat, S., Brown, J., Gomez-Rivadeneira, J., Czepiel, N., et al. (2019). Genetic associations between voltage-gated calcium channels and psychiatric disorders. International Journal of Molecular Sciences, 20, E3537.
Apple, D. M., Fonseca, R. S., & Kokovay, E. (2017). The role of adult neurogenesis in psychiatric and cognitive disorders. Brain Research, 1655, 270–276.
Association, A. P. (2000). Diagnostic and statistical manual of mental disorders.
Astori, S., Wimmer, R. D., Prosser, H. M., Corti, C., Corsi, M., Liaudet, N., et al. (2011). The Ca(V)3.3 calcium channel is the major sleep spindle pacemaker in thalamus. Proceedings of the National Academy of Sciences of the United States of America, 108, 13823–13828.
Bader, P. L., Faizi, M., Kim, L. H., Owen, S. F., Tadross, M. R., Alfa, R. W., et al. (2011). Mouse model of Timothy syndrome recapitulates triad of autistic traits. Proceedings of the National Academy of Sciences of the United States of America, 108, 15432–15437.
Baker, M., Hong, S. I., Kang, S., & Choi, D. S. (2020). Rodent models for psychiatric disorders: Problems and promises. Laboratory Animal Research, 36, 9.
Bartko, G., Horvath, S., Zador, G., & Frecska, E. (1991). Effects of adjunctive verapamil administration in chronic schizophrenic patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 15, 343–349.
Bavley, C. C., Fetcho, R. N., Burgdorf, C. E., Walsh, A. P., Fischer, D. K., Hall, B. S., et al. (2020). Cocaine- and stress-primed reinstatement of drug-associated memories elicit differential behavioral and frontostriatal circuit activity patterns via recruitment of L-type Ca2+ channels. Molecular Psychiatry, 25, 2373–2391.
Bavley, C. C., Kabir, Z. D., Walsh, A. P., Kosovsky, M., Hackett, J., Sun, H., et al. (2021). Dopamine D1R-neuron cacna1c deficiency: A new model of extinction therapy-resistant post-traumatic stress. Molecular Psychiatry, 26, 2286–2298.
Benca, R. M., Obermeyer, W. H., Thisted, R. A., & Gillin, J. C. (1992). Sleep and psychiatric disorders. A meta-analysis. Archives of General Psychiatry, 49, 651–668; discussion 669.
Bergson, P., Lipkind, G., Lee, S. P., Duban, M. E., & Hanck, D. A. (2011). Verapamil block of T-type calcium channels. Molecular Pharmacology, 79, 411–419.
Berridge, M. J. (2014). Calcium signalling and psychiatric disease: Bipolar disorder and schizophrenia. Cell and Tissue Research, 357, 477–492.
Beuckmann, C. T., Sinton, C. M., Miyamoto, N., Ino, M., & Yanagisawa, M. (2003). N-type calcium channel alpha1B subunit (Cav2.2) knock-out mice display hyperactivity and vigilance state differences. The Journal of Neuroscience, 23, 6793–6797.
Biała, G., & Langwiński, R. (1996). Effects of calcium channel antagonists on the reinforcing properties of morphine, ethanol and cocaine as measured by place conditioning. Journal of Physiology and Pharmacology, 47, 497–502.
Bigos, K. L., Mattay, V. S., Callicott, J. H., Straub, R. E., Vakkalanka, R., Kolachana, B., et al. (2010). Genetic variation in CACNA1C affects brain circuitries related to mental illness. Archives of General Psychiatry, 67, 939–945.
Blazon, M., LaCarubba, B., Bunda, A., Czepiel, N., Mallat, S., Londrigan, L., et al. (2021). N-type calcium channels control GABAergic transmission in brain areas related to fear and anxiety. OBM Neurobiology, 5. https://doi.org/10.21926/obm.neurobiol.2101083
Boehm, S., & Huck, S. (1996). Inhibition of N-type calcium channels: The only mechanism by which presynaptic alpha 2-autoreceptors control sympathetic transmitter release. The European Journal of Neuroscience, 8, 1924–1931.
Bojarski, L., Debowska, K., & Wojda, U. (2010). In vitro findings of alterations in intracellular calcium homeostasis in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34, 1367–1374.
Brimblecombe, K. R., Gracie, C. J., Platt, N. J., & Cragg, S. J. (2015). Gating of dopamine transmission by calcium and axonal N-, Q-, T- and L-type voltage-gated calcium channels differs between striatal domains. The Journal of Physiology, 593, 929–946.
Buckley, P. F., Miller, B. J., Lehrer, D. S., & Castle, D. J. (2009). Psychiatric comorbidities and schizophrenia. Schizophrenia Bulletin, 35, 383–402.
Bunda, A., LaCarubba, B., Akiki, M., & Andrade, A. (2019a). Tissue- and cell-specific expression of a splice variant in the II-III cytoplasmic loop of Cacna1b. FEBS Open Bio, 9, 1603–1616.
Bunda, A., LaCarubba, B., Bertolino, M., Akiki, M., Bath, K., Lopez-Soto, J., et al. (2019b). Cacna1b alternative splicing impacts excitatory neurotransmission and is linked to behavioral responses to aversive stimuli. Molecular Brain, 12, 81.
Burmeister, M., McInnis, M. G., & Zöllner, S. (2008). Psychiatric genetics: Progress amid controversy. Nature Reviews. Genetics, 9, 527–540.
Busquet, P., Nguyen, N. K., Schmid, E., Tanimoto, N., Seeliger, M. W., Ben-Yosef, T., et al. (2010). CaV1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype. The International Journal of Neuropsychopharmacology, 13, 499–513.
Cantor, R. M., Kono, N., Duvall, J. A., Alvarez-Retuerto, A., Stone, J. L., Alarcón, M., et al. (2005). Replication of autism linkage: Fine-mapping peak at 17q21. American Journal of Human Genetics, 76, 1050–1056.
Cardozo, D. L., & Bean, B. P. (1995). Voltage-dependent calcium channels in rat midbrain dopamine neurons: Modulation by dopamine and GABAB receptors. Journal of Neurophysiology, 74, 1137–1148.
Carman, J. S., & Wyatt, R. J. (1979). Calcium: Bivalent cation in the bivalent psychoses. Biological Psychiatry, 14, 295–336.
Casamassima, F., Hay, A. C., Benedetti, A., Lattanzi, L., Cassano, G. B., & Perlis, R. H. (2010). L-type calcium channels and psychiatric disorders: A brief review. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 153B, 1373–1390.
Chourasia, N., Ossó-Rivera, H., Ghosh, A., Von Allmen, G., & Koenig, M. K. (2019). Expanding the phenotypic spectrum of CACNA1H mutations. Pediatric Neurology, 93, 50–55.
Cipriani, A., Saunders, K., Attenburrow, M. J., Stefaniak, J., Panchal, P., Stockton, S., et al. (2016). A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development. Molecular Psychiatry, 21, 1324–1332.
Clark, M. B., Wrzesinski, T., Garcia, A. B., Hall, N. A. L., Kleinman, J. E., Hyde, T., et al. (2020). Long-read sequencing reveals the complex splicing profile of the psychiatric risk gene CACNA1C in human brain. Molecular Psychiatry, 25, 37–47.
Costa-Mattioli, M., & Monteggia, L. M. (2013). mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nature Neuroscience, 16, 1537–1543.
Cross-Disorder, G. O. T. P. G. C., Lee, S. H., Ripke, S., Neale, B. M., Faraone, S. V., Purcell, S. M., et al. (2013). Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genetics, 45, 984–994.
D’Cruz, A. M., Ragozzino, M. E., Mosconi, M. W., Shrestha, S., Cook, E. H., & Sweeney, J. A. (2013). Reduced behavioral flexibility in autism spectrum disorders. Neuropsychology, 27, 152–160.
D’Gama, A. M., Pochareddy, S., Li, M., Jamuar, S. S., Reiff, R. E., Lam, A. N., et al. (2015). Targeted DNA sequencing from autism spectrum disorder brains implicates multiple genetic mechanisms. Neuron, 88, 910–917.
Dalley, J. W., & Robbins, T. W. (2017). Fractionating impulsivity: Neuropsychiatric implications. Nature Reviews. Neuroscience, 18, 158–171.
Dao, D. T., Mahon, P. B., Cai, X., Kovacsics, C. E., Blackwell, R. A., Arad, M., et al. (2010). Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans. Biological Psychiatry, 68, 801–810.
De Rubeis, S., He, X., Goldberg, A. P., Poultney, C. S., Samocha, K., Cicek, A. E., et al. (2014). Synaptic, transcriptional and chromatin genes disrupted in autism. Nature, 515, 209–215.
Dedic, N., Pöhlmann, M. L., Richter, J. S., Mehta, D., Czamara, D., Metzger, M. W., et al. (2018). Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood. Molecular Psychiatry, 23, 533–543.
Deisseroth, K., Heist, E. K., & Tsien, R. W. (1998). Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons. Nature, 392, 198–202.
Deng, W., Aimone, J. B., & Gage, F. H. (2010). New neurons and new memories: How does adult hippocampal neurogenesis affect learning and memory. Nature Reviews. Neuroscience, 11, 339–350.
Dietrich, D., Kirschstein, T., Kukley, M., Pereverzev, A., von der Brelie, C., Schneider, T., et al. (2003). Functional specialization of presynaptic Cav2.3 Ca2+ channels. Neuron, 39, 483–496.
Dolmetsch, R. E., Pajvani, U., Fife, K., Spotts, J. M., & Greenberg, M. E. (2001). Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science, 294, 333–339.
Dolphin, A. C., & Lee, A. (2020). Presynaptic calcium channels: Specialized control of synaptic neurotransmitter release. Nature Reviews. Neuroscience, 21, 213–229.
Dubovsky, S. L., & Franks, R. D. (1983). Intracellular calcium ions in affective disorders: A review and an hypothesis. Biological Psychiatry, 18, 781–797.
Dubovsky, S. L., Thomas, M., Hijazi, A., & Murphy, J. (1994). Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder. European Archives of Psychiatry and Clinical Neuroscience, 243, 229–234.
Dupret, D., Revest, J. M., Koehl, M., Ichas, F., De Giorgi, F., Costet, P., et al. (2008). Spatial relational memory requires hippocampal adult neurogenesis. PLoS One, 3, e1959.
Durante, P., Cardenas, C. G., Whittaker, J. A., Kitai, S. T., & Scroggs, R. S. (2004). Low-threshold L-type calcium channels in rat dopamine neurons. Journal of Neurophysiology, 91, 1450–1454.
El Ghaleb, Y., Schneeberger, P. E., Fernández-Quintero, M. L., Geisler, S. M., Pelizzari, S., Polstra, A. M., et al. (2021). CACNA1I gain-of-function mutations differentially affect channel gating and cause neurodevelopmental disorders. Brain, 144, 2092–2106.
Elia, J., Glessner, J. T., Wang, K., Takahashi, N., Shtir, C. J., Hadley, D., et al. (2011). Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nature Genetics, 44, 78–84.
Emamghoreishi, M., Schlichter, L., Li, P. P., Parikh, S., Sen, J., Kamble, A., et al. (1997). High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. The American Journal of Psychiatry, 154, 976–982.
Engelhardt, K., Schwarting, R. K. W., & Wöhr, M. (2018). Mapping trait-like socio-affective phenotypes in rats through 50-kHz ultrasonic vocalizations. Psychopharmacology, 235, 83–98.
Ermolyuk, Y. S., Alder, F. G., Surges, R., Pavlov, I. Y., Timofeeva, Y., Kullmann, D. M., et al. (2013). Differential triggering of spontaneous glutamate release by P/Q-, N- and R-type Ca2+ channels. Nature Neuroscience, 16, 1754–1763.
Ferguson, B. R., & Gao, W. J. (2018). PV interneurons: Critical regulators of E/I balance for prefrontal cortex-dependent behavior and psychiatric disorders. Frontiers in Neural Circuits, 12, 37.
Ferrarelli, F., & Tononi, G. (2011). The thalamic reticular nucleus and schizophrenia. Schizophrenia Bulletin, 37, 306–315.
Ferrarelli, F., Huber, R., Peterson, M. J., Massimini, M., Murphy, M., Riedner, B. A., et al. (2007). Reduced sleep spindle activity in schizophrenia patients. The American Journal of Psychiatry, 164, 483–492.
Ferreira, M. A., O’Donovan, M. C., Meng, Y. A., Jones, I. R., Ruderfer, D. M., Jones, L., et al. (2008). Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nature Genetics, 40, 1056–1058.
Filice, F., Janickova, L., Henzi, T., Bilella, A., & Schwaller, B. (2020). The parvalbumin hypothesis of autism spectrum disorder. Frontiers in Cellular Neuroscience, 14, 577525.
Flint, J., & Munafò, M. R. (2007). The endophenotype concept in psychiatric genetics. Psychological Medicine, 37, 163–180.
Forrest, M. P., Parnell, E., & Penzes, P. (2018). Dendritic structural plasticity and neuropsychiatric disease. Nature Reviews. Neuroscience, 19, 215–234.
Fox, C. A., Mansour, A., & Watson, S. J. (1994). The effects of haloperidol on dopamine receptor gene expression. Experimental Neurology, 130, 288–303.
Gangarossa, G., Laffray, S., Bourinet, E., & Valjent, E. (2014). T-type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants. Frontiers in Behavioral Neuroscience, 8, 92.
Gatch, M. B. (2002). Nitrendipine blocks the nociceptive effects of chronically administered ethanol. Alcoholism, Clinical and Experimental Research, 26, 1181–1187.
Geurts, H. M., Corbett, B., & Solomon, M. (2009). The paradox of cognitive flexibility in autism. Trends in Cognitive Sciences, 13, 74–82.
Ghoshal, A., Uygun, D. S., Yang, L., McNally, J. M., Lopez-Huerta, V. G., Arias-Garcia, M. A., et al. (2020). Effects of a patient-derived de novo coding alteration of CACNA1I in mice connect a schizophrenia risk gene with sleep spindle deficits. Translational Psychiatry, 10, 29.
Gitlin, M. J., & Weiss, J. (1984). Verapamil as maintenance treatment in bipolar illness: A case report. Journal of Clinical Psychopharmacology, 4, 341–343.
Glen, A. I. (1985). Lithium prophylaxis of recurrent affective disorders. Journal of Affective Disorders, 8, 259–265.
Goes, F. S., McGrath, J., Avramopoulos, D., Wolyniec, P., Pirooznia, M., Ruczinski, I., et al. (2015). Genome-wide association study of schizophrenia in Ashkenazi Jews. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 168, 649–659.
Gong, B., Wang, H., Gu, S., Heximer, S. P., & Zhuo, M. (2007). Genetic evidence for the requirement of adenylyl cyclase 1 in synaptic scaling of forebrain cortical neurons. The European Journal of Neuroscience, 26, 275–288.
Goodnick, P. J. (1996). Treatment of mania: Relationship between response to verapamil and changes in plasma calcium and magnesium levels. Southern Medical Journal, 89, 225–226.
Gorman, J. M. (1996). Comorbid depression and anxiety spectrum disorders. Depression and Anxiety, 4, 160–168.
Green, E. K., Grozeva, D., Jones, I., Jones, L., Kirov, G., Caesar, S., et al. (2010). The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Molecular Psychiatry, 15, 1016–1022.
Grunze, H., Walden, J., Wolf, R., & Berger, M. (1996). Combined treatment with lithium and nimodipine in a bipolar I manic syndrome. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 20, 419–426.
Gulsuner, S., Walsh, T., Watts, A. C., Lee, M. K., Thornton, A. M., Casadei, S., et al. (2013). Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell, 154, 518–529.
Gulsuner, S., Stein, D. J., Susser, E. S., Sibeko, G., Pretorius, A., Walsh, T., et al. (2020). Genetics of schizophrenia in the South African Xhosa. Science, 367, 569–573.
Halassa, M. M., Siegle, J. H., Ritt, J. T., Ting, J. T., Feng, G., & Moore, C. I. (2011). Selective optical drive of thalamic reticular nucleus generates thalamic bursts and cortical spindles. Nature Neuroscience, 14, 1118–1120.
Hall, N. A. L., & Tunbridge, E. M. (2021). Brain-enriched CACNA1C isoforms as novel, selective targets for psychiatric indications. Neuropsychopharmacology, 47(1), 393–394.
Hamshere, M. L., Walters, J. T., Smith, R., Richards, A. L., Green, E., Grozeva, D., et al. (2013). Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Molecular Psychiatry, 18, 708–712.
Harrison, P. J., Geddes, J. R., & Tunbridge, E. M. (2018). The emerging neurobiology of bipolar disorder. Trends in Neurosciences, 41, 18–30.
Harrison, P. J., Hall, N., Mould, A., Al-Juffali, N., & Tunbridge, E. M. (2019). Cellular calcium in bipolar disorder: Systematic review and meta-analysis. Molecular Psychiatry, 26(8), 4106–4116.
Health, N. S. O. D. U. A. (2019). Substance abuse and mental service administration.
Heck, A., Fastenrath, M., Ackermann, S., Auschra, B., Bickel, H., Coynel, D., et al. (2014). Converging genetic and functional brain imaging evidence links neuronal excitability to working memory, psychiatric disease, and brain activity. Neuron, 81, 1203–1213.
Hefft, S., & Jonas, P. (2005). Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse. Nature Neuroscience, 8, 1319–1328.
Heinrichs, R. W. (2005). The primacy of cognition in schizophrenia. The American Psychologist, 60, 229–242.
Heyes, S., Pratt, W. S., Rees, E., Dahimene, S., Ferron, L., Owen, M. J., et al. (2015). Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Progress in Neurobiology, 134, 36–54.
Hidalgo, S., Campusano, J. M., & Hodge, J. J. L. (2021). The Drosophila ortholog of the schizophrenia-associated CACNA1A and CACNA1B voltage-gated calcium channels regulate memory, sleep and circadian rhythms. Neurobiology of Disease, 155, 105394.
Hofer, N. T., Tuluc, P., Ortner, N. J., Nikonishyna, Y. V., Fernándes-Quintero, M. L., Liedl, K. R., et al. (2020). Biophysical classification of a CACNA1D de novo mutation as a high-risk mutation for a severe neurodevelopmental disorder. Molecular Autism, 11, 4.
Höschl, C., & Kozený, J. (1989). Verapamil in affective disorders: A controlled, double-blind study. Biological Psychiatry, 25, 128–140.
Howes, O. D., McCutcheon, R., Owen, M. J., & Murray, R. M. (2017). The role of genes, stress, and dopamine in the development of schizophrenia. Biological Psychiatry, 81, 9–20.
Hu, Z., Liang, M. C., & Soong, T. W. (2017). Alternative splicing of L-type CaV1.2 calcium channels: Implications in cardiovascular diseases. Genes (Basel), 8, E344.
Huang, A. S., Rogers, B. P., Anticevic, A., Blackford, J. U., Heckers, S., & Woodward, N. D. (2019). Brain function during stages of working memory in schizophrenia and psychotic bipolar disorder. Neuropsychopharmacology, 44, 2136–2142.
Huys, Q. J., Maia, T. V., & Frank, M. J. (2016). Computational psychiatry as a bridge from neuroscience to clinical applications. Nature Neuroscience, 19, 404–413.
Iasevoli, F., Tomasetti, C., & de Bartolomeis, A. (2013). Scaffolding proteins of the post-synaptic density contribute to synaptic plasticity by regulating receptor localization and distribution: Relevance for neuropsychiatric diseases. Neurochemical Research, 38, 1–22.
Indelicato, E., & Boesch, S. (2021). From genotype to phenotype: Expanding the clinical spectrum of CACNA1A variants in the era of next generation sequencing. Frontiers in Neurology, 12, 639994.
Irish, S. G. C. A. T. W. T. C. C. C. (2012). Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia. Biological Psychiatry, 72, 620–628.
Iyer, R., Ungless, M. A., & Faisal, A. A. (2017). Calcium-activated SK channels control firing regularity by modulating sodium channel availability in midbrain dopamine neurons. Scientific Reports, 7, 5248.
Jansen, P. R., Watanabe, K., Stringer, S., Skene, N., Bryois, J., Hammerschlag, A. R., et al. (2019). Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways. Nature Genetics, 51, 394–403.
Jaric, I., Rocks, D., Cham, H., Herchek, A., & Kundakovic, M. (2019). Sex and estrous cycle effects on anxiety- and depression-related phenotypes in a two-hit developmental stress model. Frontiers in Molecular Neuroscience, 12, 74.
Jimerson, D. C., Post, R. M., Carman, J. S., van Kammen, D. P., Wood, J. H., Goodwin, F. K., et al. (1979). CSF calcium: Clinical correlates in affective illness and schizophrenia. Biological Psychiatry, 14, 37–51.
Kaar, S. J., Angelescu, I., Marques, T. R., & Howes, O. D. (2019). Pre-frontal parvalbumin interneurons in schizophrenia: A meta-analysis of post-mortem studies. Journal of Neural Transmission (Vienna), 126, 1637–1651.
Kabir, Z. D., Che, A., Fischer, D. K., Rice, R. C., Rizzo, B. K., Byrne, M., et al. (2017). Rescue of impaired sociability and anxiety-like behavior in adult cacna1c-deficient mice by pharmacologically targeting eIF2α. Molecular Psychiatry, 22, 1096–1109.
Kabitzke, P. A., Brunner, D., He, D., Fazio, P. A., Cox, K., Sutphen, J., et al. (2018). Comprehensive analysis of two Shank3 and the Cacna1c mouse models of autism spectrum disorder. Genes, Brain, and Behavior, 17, 4–22.
Karlsgodt, K. H., Sun, D., & Cannon, T. D. (2010). Structural and functional brain abnormalities in schizophrenia. Current Directions in Psychological Science, 19, 226–231.
Kaufman, J., & Charney, D. (2000). Comorbidity of mood and anxiety disorders. Depression and Anxiety, 12(Suppl 1), 69–76.
Kawaguchi, Y., & Kubota, Y. (1997). GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cerebral Cortex, 7, 476–486.
Kawaguchi, Y., Katsumaru, H., Kosaka, T., Heizmann, C. W., & Hama, K. (1987). Fast spiking cells in rat hippocampus (CA1 region) contain the calcium-binding protein parvalbumin. Brain Research, 416, 369–374.
Kennedy, D. P., & Adolphs, R. (2012). The social brain in psychiatric and neurological disorders. Trends in Cognitive Sciences, 16, 559–572.
Kessler, R. C., Aguilar-Gaxiola, S., Alonso, J., Chatterji, S., Lee, S., Ormel, J., et al. (2009). The global burden of mental disorders: An update from the WHO World Mental Health (WMH) surveys. Epidemiologia e Psichiatria Sociale, 18, 23–33.
Kim, C., Jeon, D., Kim, Y. H., Lee, C. J., Kim, H., & Shin, H. S. (2009). Deletion of N-type Ca(2+) channel Ca(v)2.2 results in hyperaggressive behaviors in mice. The Journal of Biological Chemistry, 284, 2738–2745.
Kisilevsky, A. E., & Zamponi, G. W. (2008). D2 dopamine receptors interact directly with N-type calcium channels and regulate channel surface expression levels. Channels (Austin, Tex.), 2, 269–277.
Kisilevsky, A. E., Mulligan, S. J., Altier, C., Iftinca, M. C., Varela, D., Tai, C., et al. (2008). D1 receptors physically interact with N-type calcium channels to regulate channel distribution and dendritic calcium entry. Neuron, 58, 557–570.
Kisko, T. M., Braun, M. D., Michels, S., Witt, S. H., Rietschel, M., Culmsee, C., et al. (2018). Cacna1c haploinsufficiency leads to pro-social 50-kHz ultrasonic communication deficits in rats. Disease Models & Mechanisms, 11, dmm034116.
Kisko, T. M., Braun, M. D., Michels, S., Witt, S. H., Rietschel, M., Culmsee, C., et al. (2020). Sex-dependent effects of Cacna1c haploinsufficiency on juvenile social play behavior and pro-social 50-kHz ultrasonic communication in rats. Genes, Brain, and Behavior, 19, e12552.
Knutson, B., Burgdorf, J., & Panksepp, J. (1998). Anticipation of play elicits high-frequency ultrasonic vocalizations in young rats. Journal of Comparative Psychology, 112, 65–73.
Kokras, N., & Dalla, C. (2014). Sex differences in animal models of psychiatric disorders. British Journal of Pharmacology, 171, 4595–4619.
Kolaj, M., & Renaud, L. P. (2001). Norepinephrine acts via alpha(2) adrenergic receptors to suppress N-type calcium channels in dissociated rat median preoptic nucleus neurons. Neuropharmacology, 41, 472–479.
Komatsu, H. (2015). Novel therapeutic GPCRs for psychiatric disorders. International Journal of Molecular Sciences, 16, 14109–14121.
Krystal, A. D. (2012). Psychiatric disorders and sleep. Neurologic Clinics, 30, 1389–1413.
Kubota, M., Murakoshi, T., Saegusa, H., Kazuno, A., Zong, S., Hu, Q., et al. (2001). Intact LTP and fear memory but impaired spatial memory in mice lacking Ca(v)2.3 (alpha(IE)) channel. Biochemical and Biophysical Research Communications, 282, 242–248.
Kuzmin, A., Zvartau, E., Gessa, G. L., Martellotta, M. C., & Fratta, W. (1992). Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice. Pharmacology, Biochemistry, and Behavior, 41, 497–500.
Lam, M., Trampush, J. W., Yu, J., Knowles, E., Davies, G., Liewald, D. C., et al. (2017). Large-scale cognitive GWAS meta-analysis reveals tissue-specific neural expression and potential nootropic drug targets. Cell Reports, 21, 2597–2613.
Lambert, R. C., Bessaïh, T., Crunelli, V., & Leresche, N. (2014). The many faces of T-type calcium channels. Pflügers Archiv, 466, 415–423.
Lee, A. S., Ra, S., Rajadhyaksha, A. M., Britt, J. K., De Jesus-Cortes, H., Gonzales, K. L., et al. (2012). Forebrain elimination of cacna1c mediates anxiety-like behavior in mice. Molecular Psychiatry, 17, 1054–1055.
Lee, A. S., De Jesús-Cortés, H., Kabir, Z. D., Knobbe, W., Orr, M., Burgdorf, C., et al. (2016). The neuropsychiatric disease-associated gene cacna1c mediates survival of young hippocampal neurons. eNeuro, 3, ENEURO.0006–16.2016.
Lee, P. H., Feng, Y. A., & Smoller, J. W. (2021). Pleiotropy and cross-disorder genetics among psychiatric disorders. Biological Psychiatry, 89, 20–31.
Lenzi, A., Marazziti, D., Raffaelli, S., & Cassano, G. B. (1995). Effectiveness of the combination verapamil and chlorpromazine in the treatment of severe manic or mixed patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 19, 519–528.
Lett, T. A., Voineskos, A. N., Kennedy, J. L., Levine, B., & Daskalakis, Z. J. (2014). Treating working memory deficits in schizophrenia: A review of the neurobiology. Biological Psychiatry, 75, 361–370.
Levine, J., Stein, D., Rapoport, A., & Kurtzman, L. (1999). High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology, 39, 63–70.
Lewis, D. A., Curley, A. A., Glausier, J. R., & Volk, D. W. (2012). Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends in Neurosciences, 35, 57–67.
Li, J., Zhao, L., You, Y., Lu, T., Jia, M., Yu, H., et al. (2015). Schizophrenia related variants in CACNA1C also confer risk of autism. PLoS One, 10, e0133247.
Li, W., Fan, C. C., Mäki-Marttunen, T., Thompson, W. K., Schork, A. J., Bettella, F., et al. (2018). A molecule-based genetic association approach implicates a range of voltage-gated calcium channels associated with schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 177, 454–467.
Lieberman, J. A., Perkins, D., Belger, A., Chakos, M., Jarskog, F., Boteva, K., et al. (2001). The early stages of schizophrenia: Speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biological Psychiatry, 50, 884–897.
Limpitikul, W. B., Dick, I. E., Ben-Johny, M., & Yue, D. T. (2016). An autism-associated mutation in CaV1.3 channels has opposing effects on voltage- and Ca(2+)-dependent regulation. Scientific Reports, 6, 27235.
Lin, E., Kuo, P. H., Liu, Y. L., Yu, Y. W., Yang, A. C., & Tsai, S. J. (2018). A deep learning approach for predicting antidepressant response in major depression using clinical and genetic biomarkers. Frontiers in Psychiatry, 9, 290.
Lipscombe, D., & Andrade, A. (2015). Calcium channel CaVα1 splice isoforms—Tissue specificity and drug action. Current Molecular Pharmacology, 8, 22–31.
Lipscombe, D., Kongsamut, S., & Tsien, R. W. (1989). Alpha-adrenergic inhibition of sympathetic neurotransmitter release mediated by modulation of N-type calcium-channel gating. Nature, 340, 639–642.
Lipscombe, D., Allen, S. E., & Toro, C. P. (2013a). Control of neuronal voltage-gated calcium ion channels from RNA to protein. Trends in Neurosciences, 36, 598–609.
Lipscombe, D., Andrade, A., & Allen, S. E. (2013b). Alternative splicing: Functional diversity among voltage-gated calcium channels and behavioral consequences. Biochimica et Biophysica Acta, 1828, 1522–1529.
Liu, Y., Harding, M., Pittman, A., Dore, J., Striessnig, J., Rajadhyaksha, A., et al. (2014). Cav1.2 and Cav1.3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area. Journal of Neurophysiology, 112, 1119–1130.
Lu, C. W., Lin, T. Y., Huang, S. K., & Wang, S. J. (2018). 5-HT1B receptor agonist CGS12066 presynaptically inhibits glutamate release in rat hippocampus. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 86, 122–130.
Luo, X., Rosenfeld, J. A., Yamamoto, S., Harel, T., Zuo, Z., Hall, M., et al. (2017). Clinically severe CACNA1A alleles affect synaptic function and neurodegeneration differentially. PLoS Genetics, 13, e1006905.
Lupien-Meilleur, A., Jiang, X., Lachance, M., Taschereau-Dumouchel, V., Gagnon, L., Vanasse, C., et al. (2021). Reversing frontal disinhibition rescues behavioural deficits in models of CACNA1A-associated neurodevelopment disorders. Molecular Psychiatry, 26(12), 7225–7246.
Malberg, J. E. (2004). Implications of adult hippocampal neurogenesis in antidepressant action. Journal of Psychiatry & Neuroscience, 29, 196–205.
Mallinger, A. G., Thase, M. E., Haskett, R., Buttenfield, J., Luckenbaugh, D. A., Frank, E., et al. (2008). Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: Preliminary findings and a discussion of therapeutic mechanisms. Bipolar Disorders, 10, 856–866.
Mallmann, R. T., Elgueta, C., Sleman, F., Castonguay, J., Wilmes, T., van den Maagdenberg, A., et al. (2013). Ablation of Ca(V)2.1 voltage-gated Ca2+ channels in mouse forebrain generates multiple cognitive impairments. PLoS One, 8, e78598.
Manoach, D. S., & Stickgold, R. (2019). Abnormal sleep spindles, memory consolidation, and schizophrenia. Annual Review of Clinical Psychology, 15, 451–479.
Manoach, D. S., Pan, J. Q., Purcell, S. M., & Stickgold, R. (2016). Reduced sleep spindles in schizophrenia: A treatable endophenotype that links risk genes to impaired cognition. Biological Psychiatry, 80, 599–608.
Marrion, N. V., & Tavalin, S. J. (1998). Selective activation of Ca2+−activated K+ channels by co-localized Ca2+ channels in hippocampal neurons. Nature, 395, 900–905.
Marschallinger, J., Sah, A., Schmuckermair, C., Unger, M., Rotheneichner, P., Kharitonova, M., et al. (2015). The L-type calcium channel Cav1.3 is required for proper hippocampal neurogenesis and cognitive functions. Cell Calcium, 58, 606–616.
MartÃnez-Rivera, A., Hao, J., Tropea, T. F., Giordano, T. P., Kosovsky, M., Rice, R. C., et al. (2017). Enhancing VTA Cav1.3 L-type Ca2+ channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens. Molecular Psychiatry, 22, 1735–1745.
Medrihan, L., Sagi, Y., Inde, Z., Krupa, O., Daniels, C., Peyrache, A., et al. (2017). Initiation of behavioral response to antidepressants by cholecystokinin neurons of the dentate gyrus. Neuron, 95, 564–576.e4.
Merikanto, I., Utge, S., Lahti, J., Kuula, L., Makkonen, T., Lahti-Pulkkinen, M., et al. (2019). Genetic risk factors for schizophrenia associate with sleep spindle activity in healthy adolescents. Journal of Sleep Research, 28, e12762.
Metz, A. E., Jarsky, T., Martina, M., & Spruston, N. (2005). R-type calcium channels contribute to afterdepolarization and bursting in hippocampal CA1 pyramidal neurons. The Journal of Neuroscience, 25, 5763–5773.
Mineka, S., Watson, D., & Clark, L. A. (1998). Comorbidity of anxiety and unipolar mood disorders. Annual Review of Psychology, 49, 377–412.
Moon, A. L., Haan, N., Wilkinson, L. S., Thomas, K. L., & Hall, J. (2018). CACNA1C: Association with psychiatric disorders, behavior, and neurogenesis. Schizophrenia Bulletin, 44, 958–965.
Moon, A. L., Brydges, N. M., Wilkinson, L. S., Hall, J., & Thomas, K. L. (2020). Cacna1c hemizygosity results in aberrant fear conditioning to neutral stimuli. Schizophrenia Bulletin, 46, sbz127.
Moosmang, S., Haider, N., Klugbauer, N., Adelsberger, H., Langwieser, N., Müller, J., et al. (2005). Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. The Journal of Neuroscience, 25, 9883–9892.
Mosheva, M., Serretti, A., Stukalin, Y., Fabbri, C., Hagin, M., Horev, S., et al. (2020). Association between CANCA1C gene rs1034936 polymorphism and alcohol dependence in bipolar disorder. Journal of Affective Disorders, 261, 181–186.
Moskvina, V., Craddock, N., Holmans, P., Nikolov, I., Pahwa, J. S., Green, E., et al. (2009). Gene-wide analyses of genome-wide association data sets: Evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Molecular Psychiatry, 14, 252–260.
Mukherjee, A., Carvalho, F., Eliez, S., & Caroni, P. (2019). Long-lasting rescue of network and cognitive dysfunction in a genetic schizophrenia model. Cell, 178, 1387–1402.e14.
Murat, S., Bigot, M., Chapron, J., König, G. M., Kostenis, E., Battaglia, G., et al. (2019). 5-HT2A receptor-dependent phosphorylation of mGlu2 receptor at Serine 843 promotes mGlu2 receptor-operated Gi/o signaling. Molecular Psychiatry, 24, 1610–1626.
Nahar, L., Delacroix, B. M., & Nam, H. W. (2021). The role of parvalbumin interneurons in neurotransmitter balance and neurological disease. Frontiers in Psychiatry, 12, 679960.
Nakagawasai, O., Onogi, H., Mitazaki, S., Sato, A., Watanabe, K., Saito, H., et al. (2010). Behavioral and neurochemical characterization of mice deficient in the N-type Ca2+ channel alpha1B subunit. Behavioural Brain Research, 208, 224–230.
Nandagopal, N., & Roux, P. P. (2015). Regulation of global and specific mRNA translation by the mTOR signaling pathway. Translation (Austin), 3, e983402.
Nelson, R. J., & Trainor, B. C. (2007). Neural mechanisms of aggression. Nature Reviews. Neuroscience, 8, 536–546.
Nestler, E. J., & Hyman, S. E. (2010). Animal models of neuropsychiatric disorders. Nature Neuroscience, 13, 1161–1169.
Newton, P. M., Orr, C. J., Wallace, M. J., Kim, C., Shin, H. S., & Messing, R. O. (2004). Deletion of N-type calcium channels alters ethanol reward and reduces ethanol consumption in mice. The Journal of Neuroscience, 24, 9862–9869.
Nguyen, R., Venkatesan, S., Binko, M., Bang, J. Y., Cajanding, J. D., Briggs, C., et al. (2020). Cholecystokinin-expressing interneurons of the medial prefrontal cortex mediate working memory retrieval. The Journal of Neuroscience, 40, 2314–2331.
Nieratschker, V., Brückmann, C., & Plewnia, C. (2015). CACNA1C risk variant affects facial emotion recognition in healthy individuals. Scientific Reports, 5, 17349.
O’Connell, K. S., McGregor, N. W., Malhotra, A., Lencz, T., Emsley, R., & Warnich, L. (2019). Variation within voltage-gated calcium channel genes and antipsychotic treatment response in a South African first episode schizophrenia cohort. The Pharmacogenomics Journal, 19, 109–114.
O’Donovan, M. C., & Owen, M. J. (2016). The implications of the shared genetics of psychiatric disorders. Nature Medicine, 22, 1214–1219.
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., et al. (2012). Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature, 485, 246–250.
Okbay, A., Baselmans, B. M., De Neve, J. E., Turley, P., Nivard, M. G., Fontana, M. A., et al. (2016). Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nature Genetics, 48, 624–633.
Oprea, T. I., & Mestres, J. (2012). Drug repurposing: Far beyond new targets for old drugs. The AAPS Journal, 14, 759–763.
Ortner, N. J., Kaserer, T., Copeland, J. N., & Striessnig, J. (2020). De novo CACNA1D Ca2+ channelopathies: Clinical phenotypes and molecular mechanism. Pflügers Archiv, 472, 755–773.
Pasparakis, E., Koiliari, E., Zouraraki, C., Tsapakis, E. M., Roussos, P., Giakoumaki, S. G., et al. (2015). The effects of the CACNA1C rs1006737 A/G on affective startle modulation in healthy males. European Psychiatry, 30, 492–498.
Pazzaglia, P. J., Post, R. M., Ketter, T. A., Callahan, A. M., Marangell, L. B., Frye, M. A., et al. (1998). Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. Journal of Clinical Psychopharmacology, 18, 404–413.
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017). Hippocampal GABAergic inhibitory interneurons. Physiological Reviews, 97, 1619–1747.
Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J. E., & Woolfrey, K. M. (2011). Dendritic spine pathology in neuropsychiatric disorders. Nature Neuroscience, 14, 285–293.
Perez-Reyes, E. (2003). Molecular physiology of low-voltage-activated t-type calcium channels. Physiological Reviews, 83, 117–161.
Pierce, R. C., Quick, E. A., Reeder, D. C., Morgan, Z. R., & Kalivas, P. W. (1998). Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine. The Journal of Pharmacology and Experimental Therapeutics, 286, 1171–1176.
Pinggera, A., Lieb, A., Benedetti, B., Lampert, M., Monteleone, S., Liedl, K. R., et al. (2015). CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels. Biological Psychiatry, 77, 816–822.
Pinggera, A., Mackenroth, L., Rump, A., Schallner, J., Beleggia, F., Wollnik, B., et al. (2017). New gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy. Human Molecular Genetics, 26, 2923–2932.
Pinggera, A., Negro, G., Tuluc, P., Brown, M. J., Lieb, A., & Striessnig, J. (2018). Gating defects of disease-causing de novo mutations in Cav1.3 Ca2+ channels. Channels (Austin, Tex.), 12, 388–402.
Post, R. M., & Kalivas, P. (2013). Bipolar disorder and substance misuse: Pathological and therapeutic implications of their comorbidity and cross-sensitisation. The British Journal of Psychiatry, 202, 172–176.
Price, W. A. (1987). Antipsychotic effects of verapamil in schizophrenia. The Hillside Journal of Clinical Psychiatry, 9, 225–230.
Price, W. A., & Pascarzi, G. A. (1987). Use of verapamil to treat negative symptoms in schizophrenia. Journal of Clinical Psychopharmacology, 7, 357.
Puopolo, M., Raviola, E., & Bean, B. P. (2007). Roles of subthreshold calcium current and sodium current in spontaneous firing of mouse midbrain dopamine neurons. The Journal of Neuroscience, 27, 645–656.
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., et al. (2014). A polygenic burden of rare disruptive mutations in schizophrenia. Nature, 506, 185–190.
Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., et al. (2019). Drug repurposing: Progress, challenges and recommendations. Nature Reviews. Drug Discovery, 18, 41–58.
Rajarajan, P., Borrman, T., Liao, W., Schrode, N., Flaherty, E., Casiño, C., et al. (2018). Neuron-specific signatures in the chromosomal connectome associated with schizophrenia risk. Science, 362, eaat4311.
Randall, A. D., & Tsien, R. W. (1997). Contrasting biophysical and pharmacological properties of T-type and R-type calcium channels. Neuropharmacology, 36, 879–893.
Redecker, T. M., Kisko, T. M., Schwarting, R. K. W., & Wöhr, M. (2019). Effects of Cacna1c haploinsufficiency on social interaction behavior and 50-kHz ultrasonic vocalizations in adult female rats. Behavioural Brain Research, 367, 35–52.
Reid, J. G., Gitlin, M. J., & Altshuler, L. L. (2013). Lamotrigine in psychiatric disorders. The Journal of Clinical Psychiatry, 74, 675–684.
Reimer, A. R., & Martin-Iverson, M. T. (1994). Nimodipine and haloperidol attenuate behavioural sensitization to cocaine but only nimodipine blocks the establishment of conditioned locomotion induced by cocaine. Psychopharmacology, 113, 404–410.
Riemann, D., Krone, L. B., Wulff, K., & Nissen, C. (2020). Sleep, insomnia, and depression. Neuropsychopharmacology, 45, 74–89.
Ripke, S., O’Dushlaine, C., Chambert, K., Moran, J. L., Kähler, A. K., Akterin, S., et al. (2013). Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nature Genetics, 45, 1150–1159.
Robinson, N., & Bergen, S. E. (2021). Environmental risk factors for schizophrenia and bipolar disorder and their relationship to genetic risk: Current knowledge and future directions. Frontiers in Genetics, 12, 686666.
Ruihua, M., Meng, Z., Nan, C., Panqi, L., Hua, G., Sijia, L., et al. (2021). Differences in facial expression recognition between unipolar and bipolar depression. Frontiers in Psychology, 12, 619368.
Saegusa, H., Kurihara, T., Zong, S., Kazuno, A., Matsuda, Y., Nonaka, T., et al. (2001). Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel. The EMBO Journal, 20, 2349–2356.
Sagi, Y., Medrihan, L., George, K., Barney, M., McCabe, K. A., & Greengard, P. (2020). Emergence of 5-HT5A signaling in parvalbumin neurons mediates delayed antidepressant action. Molecular Psychiatry, 25, 1191–1201.
Saliba, R. S., Gu, Z., Yan, Z., & Moss, S. J. (2009). Blocking L-type voltage-gated Ca2+ channels with dihydropyridines reduces gamma-aminobutyric acid type A receptor expression and synaptic inhibition. The Journal of Biological Chemistry, 284, 32544–32550.
Sanchez-Roige, S., Fontanillas, P., Elson, S. L., Gray, J. C., de Wit, H., MacKillop, J., et al. (2019). Genome-wide Association studies of impulsive personality traits (BIS-11 and UPPS-P) and drug experimentation in up to 22,861 adult research participants identify loci in the CACNA1I and CADM2 genes. The Journal of Neuroscience, 39, 2562–2572.
Schierberl, K., Hao, J., Tropea, T. F., Ra, S., Giordano, T. P., Xu, Q., et al. (2011). Cav1.2 L-type Ca2+ channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area Ca(v)1.3 channels. The Journal of Neuroscience, 31, 13562–13575.
Schizophrenia, W. G. O. T. P. G. C. (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511, 421–427.
Shimada, M., Miyagawa, T., Kawashima, M., Tanaka, S., Honda, Y., Honda, M., et al. (2010). An approach based on a genome-wide association study reveals candidate loci for narcolepsy. Human Genetics, 128, 433–441.
Sinnegger-Brauns, M. J., Hetzenauer, A., Huber, I. G., Renström, E., Wietzorrek, G., Berjukov, S., et al. (2004). Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type Ca 2+ channels. The Journal of Clinical Investigation, 113, 1430–1439.
Smail, M. A., Wu, X., Henkel, N. D., Eby, H. M., Herman, J. P., McCullumsmith, R. E., et al. (2021). Similarities and dissimilarities between psychiatric cluster disorders. Molecular Psychiatry, 26(9), 4853–4863.
Soeiro-de-Souza, M. G., Otaduy, M. C., Dias, C. Z., Bio, D. S., Machado-Vieira, R., & Moreno, R. A. (2012). The impact of the CACNA1C risk allele on limbic structures and facial emotions recognition in bipolar disorder subjects and healthy controls. Journal of Affective Disorders, 141, 94–101.
Sohal, V. S., & Rubenstein, J. L. R. (2019). Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders. Molecular Psychiatry, 24, 1248–1257.
Sonnenschein, S. F., Gomes, F. V., & Grace, A. A. (2020). Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia. Frontiers in Psychiatry, 11, 613.
Splawski, I., Timothy, K. W., Sharpe, L. M., Decher, N., Kumar, P., Bloise, R., et al. (2004). Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell, 119, 19–31.
Splawski, I., Timothy, K. W., Decher, N., Kumar, P., Sachse, F. B., Beggs, A. H., et al. (2005). Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proceedings of the National Academy of Sciences of the United States of America, 102, 8089–8096. discussion 8086.
Splawski, I., Yoo, D. S., Stotz, S. C., Cherry, A., Clapham, D. E., & Keating, M. T. (2006). CACNA1H mutations in autism spectrum disorders. The Journal of Biological Chemistry, 281, 22085–22091.
Stahl, E. A., Breen, G., Forstner, A. J., McQuillin, A., Ripke, S., Trubetskoy, V., et al. (2019). Genome-wide association study identifies 30 loci associated with bipolar disorder. Nature Genetics, 51, 793–803.
Stępnicki, P., Kondej, M., & Kaczor, A. A. (2018). Current concepts and treatments of schizophrenia. Molecules, 23, E2087.
Steriade, M., Deschênes, M., Domich, L., & Mulle, C. (1985). Abolition of spindle oscillations in thalamic neurons disconnected from nucleus reticularis thalami. Journal of Neurophysiology, 54, 1473–1497.
Striessnig, J., Koschak, A., Sinnegger-Brauns, M. J., Hetzenauer, A., Nguyen, N. K., Busquet, P., et al. (2006). Role of voltage-gated L-type Ca2+ channel isoforms for brain function. Biochemical Society Transactions, 34, 903–909.
Strom, S. P., Stone, J. L., Ten Bosch, J. R., Merriman, B., Cantor, R. M., Geschwind, D. H., et al. (2010). High-density SNP association study of the 17q21 chromosomal region linked to autism identifies CACNA1G as a novel candidate gene. Molecular Psychiatry, 15, 996–1005.
Suzuki, S., & Rogawski, M. A. (1989). T-type calcium channels mediate the transition between tonic and phasic firing in thalamic neurons. Proceedings of the National Academy of Sciences of the United States of America, 86, 7228–7232.
Sykes, L., Haddon, J., Lancaster, T. M., Sykes, A., Azzouni, K., Ihssen, N., et al. (2019). Genetic variation in the psychiatric risk gene CACNA1C modulates reversal learning across species. Schizophrenia Bulletin, 45, 1024–1032.
Takahashi, T., & Momiyama, A. (1993). Different types of calcium channels mediate central synaptic transmission. Nature, 366, 156–158.
Takata, A., Ionita-Laza, I., Gogos, J. A., Xu, B., & Karayiorgou, M. (2016). De novo synonymous mutations in regulatory elements contribute to the genetic etiology of autism and schizophrenia. Neuron, 89, 940–947.
Takata, A., Miyake, N., Tsurusaki, Y., Fukai, R., Miyatake, S., Koshimizu, E., et al. (2018). Integrative analyses of de novo mutations provide deeper biological insights into autism spectrum disorder. Cell Reports, 22, 734–747.
Takenaka, S., Sera, N., Tokiwa, H., Hirohata, I., & Hirohata, T. (1989). Identification of mutagens in Japanese pickles. Mutation Research, 223, 35–40.
Tatti, R., Haley, M. S., Swanson, O. K., Tselha, T., & Maffei, A. (2017). Neurophysiology and regulation of the balance between excitation and inhibition in neocortical circuits. Biological Psychiatry, 81, 821–831.
Temme, S. J., Bell, R. Z., Fisher, G. L., & Murphy, G. G. (2016). Deletion of the mouse homolog of CACNA1C disrupts discrete forms of hippocampal-dependent memory and neurogenesis within the dentate gyrus. eNeuro, 3, ENEURO.0118–16.2016.
Terrillion, C. E., Dao, D. T., Cachope, R., Lobo, M. K., Puche, A. C., Cheer, J. F., et al. (2017). Reduced levels of Cacna1c attenuate mesolimbic dopamine system function. Genes, Brain, and Behavior, 16, 495–505.
Thankachan, S., Katsuki, F., McKenna, J. T., Yang, C., Shukla, C., Deisseroth, K., et al. (2019). Thalamic reticular nucleus parvalbumin neurons regulate sleep spindles and electrophysiological aspects of schizophrenia in mice. Scientific Reports, 9, 3607.
Tigaret, C. M., Lin, T. E., Morrell, E. R., Sykes, L., Moon, A. L., O’Donovan, M. C., et al. (2021). Neurotrophin receptor activation rescues cognitive and synaptic abnormalities caused by hemizygosity of the psychiatric risk gene Cacna1c. Molecular Psychiatry, 26, 1748–1760.
Tombácz, D., Maróti, Z., Kalmár, T., Csabai, Z., Balázs, Z., Takahashi, S., et al. (2017). High-coverage whole-exome sequencing identifies candidate genes for suicide in victims with major depressive disorder. Scientific Reports, 7, 7106.
Tsuang, M. T., Bar, J. L., Stone, W. S., & Faraone, S. V. (2004). Gene-environment interactions in mental disorders. World Psychiatry, 3, 73–83.
Tyagi, S., Bendrick, T. R., Filipova, D., Papadopoulos, S., & Bannister, R. A. (2019). A mutation in CaV2.1 linked to a severe neurodevelopmental disorder impairs channel gating. The Journal of General Physiology, 151, 850–859.
Uhrig, S., Vandael, D., Marcantoni, A., Dedic, N., Bilbao, A., Vogt, M. A., et al. (2017). Differential roles for L-type calcium channel subtypes in alcohol dependence. Neuropsychopharmacology, 42, 1058–1069.
Voglis, G., & Tavernarakis, N. (2006). The role of synaptic ion channels in synaptic plasticity. EMBO Reports, 7, 1104–1110.
Völkening, B., Schönig, K., Kronenberg, G., Bartsch, D., & Weber, T. (2017). Deletion of psychiatric risk gene Cacna1c impairs hippocampal neurogenesis in cell-autonomous fashion. Glia, 65, 817–827.
Waltz, J. A. (2017). The neural underpinnings of cognitive flexibility and their disruption in psychotic illness. Neuroscience, 345, 203–217.
Wek, R. C., & Cavener, D. R. (2007). Translational control and the unfolded protein response. Antioxidants & Redox Signaling, 9, 2357–2371.
Whittington, M. A., Dolin, S. J., Patch, T. L., Siarey, R. J., Butterworth, A. R., & Little, H. J. (1991). Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment. British Journal of Pharmacology, 103, 1669–1676.
Xie, Y., Huang, D., Wei, L., & Luo, X. J. (2018). Further evidence for the genetic association between CACNA1I and schizophrenia. Hereditas, 155, 16.
Xu, W., Liu, Y., Chen, J., Guo, Q., Liu, K., Wen, Z., et al. (2018). Genetic risk between the CACNA1I gene and schizophrenia in Chinese Uygur population. Hereditas, 155, 5.
Yatsenko, S. A., Hixson, P., Roney, E. K., Scott, D. A., Schaaf, C. P., Ng, Y. T., et al. (2012). Human subtelomeric copy number gains suggest a DNA replication mechanism for formation: Beyond breakage-fusion-bridge for telomere stabilization. Human Genetics, 131, 1895–1910.
Yau, S. Y., Li, A., & So, K. F. (2015). Involvement of adult hippocampal neurogenesis in learning and forgetting. Neural Plasticity, 2015, 717958.
Zaitsev, A. V., Povysheva, N. V., Lewis, D. A., & Krimer, L. S. (2007). P/Q-type, but not N-type, calcium channels mediate GABA release from fast-spiking interneurons to pyramidal cells in rat prefrontal cortex. Journal of Neurophysiology, 97, 3567–3573.
Zamponi, G. W., Striessnig, J., Koschak, A., & Dolphin, A. C. (2015). The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacological Reviews, 67, 821–870.
Zhang, J., Tan, L., Ren, Y., Liang, J., Lin, R., Feng, Q., et al. (2016). Presynaptic excitation via GABAB receptors in habenula cholinergic neurons regulates fear memory expression. Cell, 166, 716–728.
Zhang, T., Zhu, L., Ni, T., Liu, D., Chen, G., Yan, Z., et al. (2018). Voltage-gated calcium channel activity and complex related genes and schizophrenia: A systematic investigation based on Han Chinese population. Journal of Psychiatric Research, 106, 99–105.
Zharkovsky, A., Tötterman, A. M., Moisio, J., & Ahtee, L. (1993). Concurrent nimodipine attenuates the withdrawal signs and the increase of cerebral dihydropyridine binding after chronic morphine treatment in rats. Naunyn-Schmiedeberg’s Archives of Pharmacology, 347, 483–486.
Zhou, Y., Niimi, K., Li, W., & Takahashi, E. (2015). Role of Cav2. 2-mediated signaling in depressive behaviors. Integrative Molecular Medicine, 2, 369–372.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Berry, C., Sun, H., Tkachev, V., Rajadhyaksha, A.M., Andrade, A. (2022). Novel Insights into the Role of Voltage-Gated Calcium Channel Genes in Psychiatric Disorders. In: Zamponi, G.W., Weiss, N. (eds) Voltage-Gated Calcium Channels . Springer, Cham. https://doi.org/10.1007/978-3-031-08881-0_21
Download citation
DOI: https://doi.org/10.1007/978-3-031-08881-0_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-08880-3
Online ISBN: 978-3-031-08881-0
eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)